Transplantation outcomes in GATA2 deficiency have been prospectively analyzed in some clinical trials (73, 74, 78), perhaps because the unique clinical features promoted participation in clinical trials. This evidence concerns the gene GATA2 and hyperinsulinemic hypoglycemia, familial, 4.